Hypophosphatasia: Clinical Clues and Management Considerations

Area of Science:

• Endocrinology
• Genetics
• Metabolic Bone Disease

Background:

• Hypophosphatasia (HPP) is a rare inherited metabolic bone disorder caused by mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNSALP).
• Defective bone mineralization results from low serum alkaline phosphatase activity, leading to skeletal abnormalities.
• Early recognition is crucial for appropriate management and to prevent long-term complications.

Observation:

• A 49-year-old female presented with a history of recurrent fractures and dental anomalies, initially evaluated for osteopenia.
• Laboratory investigations revealed hypophosphatasia (low serum alkaline phosphatase) and low vitamin B6 levels.
• Genetic testing confirmed the diagnosis of hypophosphatasia.

Findings:

• The case illustrates typical clinical and biochemical features of hypophosphatasia.
• Low vitamin B6 levels were noted as a potential diagnostic clue.
• Genetic confirmation is the gold standard for diagnosing hypophosphatasia.

Implications:

• This case underscores the importance of considering hypophosphatasia in patients with unexplained fractures and dental issues.
• Management strategies are evolving, with teriparatide as a potential anabolic agent.
• Caution is advised against using bisphosphonates in hypophosphatasia due to potential adverse effects on bone healing.